Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery

Expert Opinion on Drug Discovery
Ye Fang

Abstract

Drug discovery is a long and costly process. Innovations and paradigm shifts are essential for continuous improvement in the productivity of pharmaceutical R&D. The author reviews the progress of label-free cell phenotypic and computational approaches in early drug discovery since 2004 and proposes a novel paradigm, which combines both approaches. Label-free cell phenotypic profiling techniques offer an unprecedented and integrated approach to comprehend drug-target interactions in their native environments. However, these approaches have disadvantages associated with the lack of molecular details. Computational approaches, including ligand-, structure- and phenotype-based virtual screens, have become versatile tools in the early drug discovery process. However, these approaches mostly predict the binding of drug molecules to targets of interest and are limited to targets that are either well annotated for ligands or that are structurally resolved. Thus, combining label-free cell phenotypic profiling with computational approaches can provide a potential paradigm to accelerate novel drug discovery by taking advantages of the best of both approaches.

References

Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Jun 11, 1999·Journal of Chemical Information and Computer Sciences·M J McGregor, S M Muskal
Feb 8, 2000·Journal of Chemical Information and Computer Sciences·M J McGregor, S M Muskal
Jul 18, 2002·Nature Reviews. Drug Discovery·Tom L BlundellChris Abell
Sep 6, 2002·Journal of Medicinal Chemistry·Yvonne C MartinLinda M Traphagen
Nov 5, 2002·Nature Reviews. Drug Discovery·Jürgen Bajorath
Jan 28, 2003·Drug Discovery Today·Paul D Lyne
Jan 23, 2004·Journal of Medicinal Chemistry·Connie OshiroPeter D J Grootenhuis
Mar 17, 2004·Biochimica Et Biophysica Acta·Michal ViethHorst Hemmerle
Apr 3, 2004·Nature Reviews. Drug Discovery·Bryan L RothWesley K Kroeze
Apr 28, 2004·Drug Discovery Today·Andrew L HopkinsAlexander Alex
Oct 12, 2004·Proteins·Sergei Izrailev, Michael A Farnum
Dec 17, 2004·Nature·Brian K Shoichet
Jan 26, 2005·Journal of Chemical Information and Modeling·John J Irwin, Brian K Shoichet
Apr 6, 2005·Drug Discovery Today·Charles P Hart
Dec 13, 2005·Journal of Medicinal Chemistry·Tímea PolgárGyörgy M Keseru
Dec 24, 2005·Nature Chemical Biology·Anton F FliriRobert A Volkmann
Feb 9, 2006·Nature Biotechnology·Nathalie MaloRobert Nadon
Jun 8, 2006·Annual Review of Biochemistry·Alexander Levitzki, Eyal Mishani
Jun 13, 2006·Biophysical Journal·Ye FangJitendra Balakrishnan
Jun 24, 2006·Drug Discovery Today·Gerhard Klebe
Jul 15, 2006·Nature Biotechnology·Gaia V PaoliniAndrew L Hopkins
Aug 5, 2006·Nature Reviews. Drug Discovery·Robert A CopelandThomas D Meek
Sep 23, 2006·Nature Reviews. Cancer·Robert H Shoemaker
Oct 19, 2006·Trends in Biotechnology·Sophia AnaniadouJun-ichi Tsujii
Nov 30, 2006·Drug Discovery Today·Peter Willett
Dec 2, 2006·Nature Reviews. Drug Discovery·John P OveringtonAndrew L Hopkins
Dec 13, 2006·Journal of Medicinal Chemistry·Jonas BoströmStefan Schmitt
Feb 9, 2007·Nature Biotechnology·Michael J KeiserBrian K Shoichet
Apr 24, 2007·Journal of Medicinal Chemistry·Brian Y FengChristopher P Austin
Oct 9, 2007·Nature Biotechnology·Muhammed A YildirimMarc Vidal
Nov 1, 2007·Nature Reviews. Drug Discovery·Paul D Leeson, Brian Springthorpe
Mar 13, 2008·Journal of Medicinal Chemistry·Kerim BabaogluBrian K Shoichet
May 13, 2008·Nature Reviews. Cancer·Klaus Strebhardt, Axel Ullrich
Jun 19, 2008·Nature Chemical Biology·Martin Audet, Michel Bouvier
Jul 16, 2008·Science·Monica CampillosPeer Bork
Dec 4, 2008·Drug Discovery Today·Bradley A JusticeRobin A Felder
Jan 13, 2009·Drug Discovery Today·Yongliang YangAmin I Kassis
Apr 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Peter KolbBrian K Shoichet
May 22, 2009·Nature·Daniel M RosenbaumBrian K Kobilka
Jul 18, 2009·Nature Reviews. Drug Discovery·Terry P Kenakin
Jul 31, 2009·Journal of Receptor and Signal Transduction Research·Róisín M OwensMoonsoo M Jin
Sep 8, 2009·Current Opinion in Biotechnology·Peter KolbBrian K Shoichet
Oct 21, 2009·Nature Chemical Biology·David D BoehrPeter E Wright
Oct 22, 2009·Chemical Biology & Drug Design·Dirk BeherMinghan Wang

❮ Previous
Next ❯

Citations

Feb 24, 2016·International Journal of Molecular Sciences·Wei ZhouGe Zhang
Aug 28, 2015·Future Medicinal Chemistry·Ye Fang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.